145 related articles for article (PubMed ID: 29622689)
1. Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity.
Fuertes M; Sapochnik M; Tedesco L; Senin S; Attorresi A; Ajler P; Carrizo G; Cervio A; Sevlever G; Bonfiglio JJ; Stalla GK; Arzt E
Endocr Relat Cancer; 2018 Jun; 25(6):665-676. PubMed ID: 29622689
[TBL] [Abstract][Full Text] [Related]
2. Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
Fuertes M; Elguero B; Gonilski-Pacin D; Herbstein F; Rosmino J; Ciancio Del Giudice N; Fiz M; Falcucci L; Arzt E
Front Endocrinol (Lausanne); 2022; 13():864780. PubMed ID: 35528020
[TBL] [Abstract][Full Text] [Related]
3. Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma.
He W; Huang L; Shen X; Yang Y; Wang D; Yang Y; Zhu X
Gene; 2017 Mar; 603():54-60. PubMed ID: 27989771
[TBL] [Abstract][Full Text] [Related]
4. RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.
Shan B; Gerez J; Haedo M; Fuertes M; Theodoropoulou M; Buchfelder M; Losa M; Stalla GK; Arzt E; Renner U
Endocr Relat Cancer; 2012 Feb; 19(1):13-27. PubMed ID: 22009797
[TBL] [Abstract][Full Text] [Related]
5. PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines.
Minematsu T; Egashira N; Kajiya H; Takei M; Takekoshi S; Itoh Y; Tsukamoto H; Itoh J; Sanno N; Teramoto A; Osamura RY
Endocr Pathol; 2007; 18(1):8-15. PubMed ID: 17652795
[TBL] [Abstract][Full Text] [Related]
6. PTTG and Ki-67 expression in pituitary adenomas.
Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
[TBL] [Abstract][Full Text] [Related]
7. Functional role of estrogen in pituitary tumor pathogenesis.
Heaney AP; Fernando M; Melmed S
J Clin Invest; 2002 Jan; 109(2):277-83. PubMed ID: 11805140
[TBL] [Abstract][Full Text] [Related]
8. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.
Hunter JA; Skelly RH; Aylwin SJ; Geddes JF; Evanson J; Besser GM; Monson JP; Burrin JM
Eur J Endocrinol; 2003 Feb; 148(2):203-11. PubMed ID: 12590639
[TBL] [Abstract][Full Text] [Related]
9. Role of RSUME in inflammation and cancer.
Antico Arciuch VG; Tedesco L; Fuertes M; Arzt E
FEBS Lett; 2015 Nov; 589(22):3330-5. PubMed ID: 26297826
[TBL] [Abstract][Full Text] [Related]
10. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of pituitary tumor transforming gene in tumorigenesis.
Tfelt-Hansen J; Kanuparthi D; Chattopadhyay N
Clin Med Res; 2006 Jun; 4(2):130-7. PubMed ID: 16809406
[TBL] [Abstract][Full Text] [Related]
12. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
13. Clusterin and FOXL2 act concordantly to regulate pituitary gonadotroph adenoma growth.
Chesnokova V; Zonis S; Wawrowsky K; Tani Y; Ben-Shlomo A; Ljubimov V; Mamelak A; Bannykh S; Melmed S
Mol Endocrinol; 2012 Dec; 26(12):2092-103. PubMed ID: 23051594
[TBL] [Abstract][Full Text] [Related]
14. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
[TBL] [Abstract][Full Text] [Related]
15. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas.
Gruppetta M; Formosa R; Falzon S; Ariff Scicluna S; Falzon E; Degeatano J; Vassallo J
Pituitary; 2017 Jun; 20(3):358-371. PubMed ID: 28342098
[TBL] [Abstract][Full Text] [Related]
17. Oncogene activation in pituitary tumors.
Yu R; Melmed S
Brain Pathol; 2001 Jul; 11(3):328-41. PubMed ID: 11414475
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
19. p21(Cip1) restrains pituitary tumor growth.
Chesnokova V; Zonis S; Kovacs K; Ben-Shlomo A; Wawrowsky K; Bannykh S; Melmed S
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17498-503. PubMed ID: 18981426
[TBL] [Abstract][Full Text] [Related]
20. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.
Wu Y; Tedesco L; Lucia K; Schlitter AM; Garcia JM; Esposito I; Auernhammer CJ; Theodoropoulou M; Arzt E; Renner U; Stalla GK
Oncotarget; 2016 Sep; 7(36):57878-57893. PubMed ID: 27506944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
